<--- Back to Details
First PageDocument Content
Innovative Medicines Initiative / Pharmaceutical industry / Science and technology in Europe / European Federation of Pharmaceutical Industries and Associations / Bayer Schering Pharma / UCB / Janssen Pharmaceutica / Schering AG / Pharmaceutical sciences / Europe / Pharmacology
Date: 2015-03-05 07:41:37
Innovative Medicines Initiative
Pharmaceutical industry
Science and technology in Europe
European Federation of Pharmaceutical Industries and Associations
Bayer Schering Pharma
UCB
Janssen Pharmaceutica
Schering AG
Pharmaceutical sciences
Europe
Pharmacology

Industry Meets Academia PRAGUE 2015

Add to Reading List

Source URL: www.biocev.eu

Download Document from Source Website

File Size: 2,07 MB

Share Document on Facebook

Similar Documents

Press Release  EBiSC – the first European bank for induced pluripotent stem cells Pharmaceutical companies who are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) join forces wi

Press Release EBiSC – the first European bank for induced pluripotent stem cells Pharmaceutical companies who are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) join forces wi

DocID: 1tXAK - View Document

EFPIA Disclosure Code: Your Questions Answered March 2016 #pharmadisclosure  www.efpia.eu

EFPIA Disclosure Code: Your Questions Answered March 2016 #pharmadisclosure www.efpia.eu

DocID: 1rsSj - View Document

European Federation of Biotechnology Microbial Physiology Section  The 2007 Annual meeting of the EFB Microbial Physiology Section was held aton Monday 17th September during ECB13, Fira de Barcelona in Barcelona,

European Federation of Biotechnology Microbial Physiology Section The 2007 Annual meeting of the EFB Microbial Physiology Section was held aton Monday 17th September during ECB13, Fira de Barcelona in Barcelona,

DocID: 1rnG2 - View Document

ABIRISK ABIRISK Project Officially Started A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments for

ABIRISK ABIRISK Project Officially Started A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments for

DocID: 1rlyu - View Document

About the EFPIA Disclosure Code Securing the future of collaboration between industry and healthcare professionals Collaboration between industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) be

About the EFPIA Disclosure Code Securing the future of collaboration between industry and healthcare professionals Collaboration between industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) be

DocID: 1rkGi - View Document